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Abstract  
Background: Phototherapy with narrow-band ultraviolet B (narrow-band UVB) is 
clinically effective treatment for atopic dermatitis. In the present study, we examined the 
effects of intranasal irradiation with narrow-band UVB on nasal symptom, upregulation 




nasal mucosa of allergic rhinitis (AR) model rat.    
Methods: AR model rats were intranasally irradiated with 310 nm of narrow-band UVB. 
Nasal mucosal levels of H1R mRNA were measured using real-time quantitative reverse 
transcriptase (RT)-PCR. DNA damage was evaluated using cyclobutane pyrimidine dimer 
(CPD) immunostaining. 
Results: In toluene 2, 4-diisocyanate (TDI)-sensitized rats, TDI provoked sneezes and 
H1R gene expression in the nasal mucosa. Intranasal pre-irradiation with 310 nm narrow-
band UVB at doses of 600 and 1400, but not 200 mJ/cm2 significantly inhibited the 
number of sneezes and upregulation of H1R gene expression provoked by TDI. CPD-
positive cells appeared in the nasal mucosa after intranasal narrow-band UVB irradiation 
at a dose of 1400, but not 200 and 600 mJ/cm2. The suppression of TDI-provoked sneezes 
and upregulation of H1R gene expression lasted 24 h, but not 48 h, after narrow-band 
UVB irradiation with a dose of 600 mJ/cm2. 
Conclusions: Intranasal pre-irradiation with narrow-band UVB dose-dependently 
inhibited sneezes and upregulation of H1R gene expression of the nasal mucosa in AR 
model rats, suggesting that the inhibition of nasal upregulation of H1R gene expression 
suppressed nasal symptom. The suppression after narrow-band UVB irradiation at a dose 




indicated that low-dose narrow-band UVB phototherapy could be effectively and safely 
used for AR treatment in a clinical setting. 
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 Phototherapy with narrow-band ultraviolet B (narrow-band UVB, wavelength from 
308-313 nm) is clinically effective treatment for skin diseases, such as atopic dermatitis 
(AD) and psoriasis.1-3 Because allergic rhinitis (AR) shares a common pathophysiology 
with AD, narrow-band UVB phototherapy could be effective treatment for AR. However, 
the dermatological Philips TL01 narrow-band UVB lamp is too big for intranasal 
irradiation. To overcome this problem, light-emitting diodes (LEDs) that emit their energy 
mostly at 310 nm wavelength narrow-band UVB, have been developed; these LEDs are 
small enough for intranasal irradiation.4 
 Histamine is a main chemical mediator in the AR development and nasal symptoms 
are mediated by histamine signaling via the histamine H1 receptor (H1R).
5 H1R gene 
expression is upregulated in the nasal mucosa of patients with AR, 6, 7 and levels of H1R 
mRNA are correlated with the intensity of nasal symptoms in AR patients.8 Therefore, 
suppression of the upregulation of H1R mRNA in the nasal mucosa is a promising 
therapeutic strategy for the treatment of AR.9-14 
 In a previous study, we reported that irradiation with the 310 nm narrow-band UVB 
wavelength-specifically, reversibly, and dose-dependently suppresses phorbol-12-




epithelial HeLa cells.4 We also reported that irradiation with narrow-band UVB inhibits 
phosphorylation of extracellular signal-regulated kinase (ERK) in the H1R signaling 
pathway, suggesting that the suppression of ERK phosphorylation is underlying 
mechanism of the inhibition of PMA-induced upregulation of H1R gene expression in 
HeLa cells.15,16 In this study, we examined whether irradiation with narrow-band UVB 
suppressed upregulation of H1R mRNA in vivo. For this purpose, we used rats sensitized 
with toluene 2, 4-diisocyanate (TDI) as an AR model. We examined whether intranasal 
narrow-band UVB irradiation suppressed TDI-provoked upregulation of H1R mRNA in 
the nasal mucosa and nasal symptom of TDI model rats. We also examined whether 
intranasal irradiation with narrow-band UVB induced apoptosis and DNA damage in 




Brown Norway rats (male, six-week-old, 200-250 g, Japan SLC, Hamamatsu, Japan) 
were used for this study. Rats were allowed free access to water and food. Room 
temperature and humidity were maintained at 25 ± 2 °C and 55 ± 10%, respectively, with 




technique described by Nurul IM et al.9 Briefly, 10 L of a 10% solution of TDI in ethyl 
acetate (Wako Pure Chemical, Osaka, Japan) was applied bilaterally to the rats nasal 
vestibule once a day for 5 days (days 1-5). After a 2-d interval, the sensitization procedure 
was repeated (days 8-12). Nine days after the second sensitization, 10 L of TDI solution 
was applied to the nasal vestibule again to provoke nasal symptom in TDI-sensitized rats 
(Fig. 1). Control rats were treated with ethyl acetate using the same procedure. 
Immediately after TDI provocation, the number of sneezes was counted for 10 min. The 
nasal septum mucosa was dissected 4 h after TDI provocation. Samples were stocked in 
RNAlater (Thermo Fisher Scientific, Waltham, MA, USA) at -80 ℃ until assayed. We 
performed all experimental procedures in accordance with the guidelines and approval of  
the Animal Research Committee of Tokushima University.  
 
Narrow-band UVB irradiation 
An LED that emits its energy mostly at 310 nm wavelength, within the narrow-band 
UVB (Nichia Corporation, Tokushima, Japan), was used for intranasal irradiation through 
the bilateral nostrils of TDI-sensitized rats on day 22. An UVX Radiometer (UVP, Upland, 
CA) was used to measure the dosages of narrow-band UVB. The distance between the 




mm, that was the same as the distance from the rats nostrils to nasal mucosa. Two probes 
were placed in front of each rat nostril and adjusted 30-degree angle outside to the body 
axis. Narrow-band UVB at 310 nm was used to irradiate rat nostrils at doses of 200, 600 
and 1400 mJ/cm2 under anesthesia with pentobarbital with a dose of 30 mg/kg, 
intraperitoneally. Three hours after irradiation, we applied TDI to nasal vestibule 
bilaterally to provoke nasal symptom (Fig. 1). 
 
Real-time quantitative reverse transcriptase (RT)-PCR 
We homogenized nasal mucosa samples using a polytron homogenizer (PT-K; 
Kinematica, AG, Luzern, Switzerland).   We then isolated total RNA using the RNAiso 
Plus reagent (Takara Bio Inc., Kyoto, Japan). RNA samples were reverse transcribed to 
cDNA using a PrimeScript RT Reagent Kit (Takara Bio Inc., Shiga, Japan). TaqMan 
primers and the probe were designed using Primer Express Software (Applied Biosystems, 
Foster City, CA, USA) as follows: forward primer for rat H1R, 5’-
TATGTGTCCGGGCTGCACT-3’; reverse primer for rat H1R, 5’-
CGCCATGATAAAACCCAACTG-3’; and TaqMan probe, FAM-
CCGAGAGCGGAAGGCAGCCA-TAMURA. To standardize the starting material, 




expressed data as a ratio of GAPDH mRNA.  
 
Induction of apoptosis evaluated by TdT-mediated dUTP nick end labeling (TUNEL) 
staining 
Narrow-band UVB-induced apoptosis in the nasal mucosa cells was detected by 
TUNEL staining in TDI-sensitized rats. Three hours after narrow-band UVB irradiation  
with doses of 200, 600 and 1400 mJ/cm2, we applied TDI to the nasal vestibule to 
provoke nasal symptom. Four hours after provocation, we dissected and fixed the nasal 
mucosa in 4% paraformaldehyde for approximately 24 h, washed in phosphate buffered 
saline (PBS), and transferred to 30% sucrose for cryoprotection. The nasal mucosa was 
embedded in optimal cutting temperature (OCT) compound (Tissue-Tek; Sakura Fine 
Technical, Tokyo, Japan), rapidly frozen on dry ice, and then cut into 10 μm-thick 
sections using a cryostat (CM3050s; Leica Instrument, Nussloch, Germany). The 
TUNEL staining was performed by using the DeadEnd Fluorometric TUNEL System 
(Promega, Madison, WI, USA). The tissue sections on a glass slide were dried, washed 
in PBS to remove the OCT compound, incubated with 20 μg/mL Proteinase K for 10 
min at 25 ℃, washed in PBS for 5 min, and immersed in 4% paraformaldehyde for 5 




and washed in PBS for 5 min. Equilibration Buffer (100 μL) was added to the tissue 
sections and incubated for 10 min at 25 ℃. The TdT reaction mixture (50 μL) was added 
to the tissue sections and incubated for 60 min at 37 ℃ in a humidified chamber. The 
tissue sections were then immersed in 2× saline sodium citrate (SSC) for 15 min 25 ℃, 
washed in PBS three times for 5 min each, counterstained with 1 μg/mL propidium 
iodide for 15 min, and washed in PBS three times for 5 min each. Thereafter, the tissue 
sections were observed using a fluorescent microscope (BZ-X710; Keyence, Osaka, 
Japan). As a positive control, the tissue sections dissected from control rats were treated 
with RQ1 RNase-Free DNase (Promega, Madison, WI, USA). Before the equilibration 
buffer was added, 500 μL RQ1 DNase reaction buffer was added to the tissue sections 
and incubated for 5 min at 25 ℃. After the tissue sections were dried, 10 u/mL RQ1 
RNase-Free DNase was added to the tissue sections and incubated for 10 min at 25 ℃. 
The tissue sections were washed in PBS, and then the TUNEL reaction was performed 
the same as described above. 
 
DNA damage evaluated by cyclobutane pyrimidine dimer (CPD) immunostaining 
Narrow-band UVB-induced DNA damage in nasal mucosa cells was detected by 




irradiation at doses of 200, 600 and 1400 mJ/cm2, we applied TDI to the nasal vestibule 
to provoke nasal symptom. Four hours after provocation, we dissected the nasal mucosa, 
then fixed in 4% paraformaldehyde for approximately 24 h, washed in PBS, and 
transferred to 30% sucrose for cryoprotection. The nasal mucosa was embedded in OCT 
compound (Tissue-Tek; Sakura Fine Technical, Tokyo, Japan), rapidly frozen on dry ice, 
and then cut into 10 μm-thick sections using a cryostat (CM3050s; Leica Instrument, 
Nussloch, Germany). The tissue sections on a glass slide were dried, washed in PBS-
Tween (PBST) to remove the OCT compound, and subsequently boiled at 85 ℃ in 10 
mM citric acid solution for 10 min. The tissue sections were incubated on ice for 1 h, 
washed in PBST for 5 min, blocked for 1 h at 25 ℃ in a solution of 3% goat serum in 
PBST, and then incubated with anti-CPD antibody (Cosmo Bio Co., Ltd., Tokyo, Japan) 
diluted 1:400 in PBST at 4 ℃ overnight. Finally, the tissue sections were incubated with 
secondary antibody, fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG 
antibody (Jackson ImmunoResearch, West Grove, Pennsylvania, USA) diluted 1:400 in 
PBST at 25 ℃ for 2 h, counterstained with 1 μg/mL propidium iodide for 15 min, and 
washed in PBST three times for 5 min each. Thereafter, the tissue sections were observed 





Time course after narrow-band UVB irradiation 
We used 310 nm of narrow-band UVB at a dose of 600 mJ/cm2 to intranasally 
irradiate TDI-sensitized rats, and TDI provocation was performed 3, 24 and 48 h later on 
day 22 (Fig. 1). We counted the number of sneezes for 10 min, then dissected the nasal 
mucosa 4 h after provocation, and samples were stored as described above. Nasal mucosa 
levels of H1R mRNA were measured using real-time quantitative RT-PCR, as described 
above.  
We detected narrow-band UVB-induced apoptosis and DNA damage in nasal mucosa 
cells using TUNEL staining and CPD immunostaining, respectively, as described above. 
 
Statistical analysis 
The results are presented as the mean ± SEM. Statistical analyses were performed 
using analysis of variance with Dunnett’s test using the GraphPad Prism software 








the nasal mucosa and sneezes of TDI-sensitized rats 
In TDI-sensitized rats, TDI provocation significantly increased H1R mRNA levels in 
the nasal mucosa. Intranasal pre-irradiation with narrow-band UVB with doses of 600 
and 1400, but not 200 mJ/cm2 significantly inhibited TDI-provoked H1R mRNA 
upregulation (Fig. 2A). TDI provocation significantly increased the number of sneezes in 
TDI-sensitized rats. Intranasal pre-irradiation with narrow-band UVB with doses of 600 
and 1400, but not 200 mJ/cm2 significantly inhibited the number of TDI-induced sneezes 
of TDI-sensitized rats (Fig. 2B).  
 
Induction of apoptosis after narrow-band UVB irradiation in nasal mucosa cells of TDI-
sensitized rats 
After intranasal narrow-band UVB irradiation with a dose of 200 mJ/cm2, no 
TUNEL-positive cells appeared in the nasal mucosa of TDI-sensitized rats. However, 
after intranasal narrow-band UVB irradiation with doses of 600 and 1400 mJ/cm2, a few 
and some TUNEL-positive cells appeared in the nasal mucosa, respectively (Fig. 3).  
 





After intranasal narrow-band UVB irradiation at doses of 200 and 600 mJ/cm2, no 
CPD-positive cells appeared in the nasal mucosa of TDI-sensitized rats. Meanwhile, after 
intranasal narrow-band UVB irradiation at a dose of 1400 mJ/cm2, many CPD-positive 
cells appeared in the nasal mucosa (Fig. 4). 
 
Time course after narrow-band UVB irradiation 
Intranasal narrow-band UVB pre-irradiation at a dose of 600 mJ/cm2 significantly 
inhibited TDI-provoked sneezes and upregulation of H1R gene expression 3 and 24 h, 
but not 48 h, after irradiation (Fig. 5). A few TUNEL-positive cells appeared in the nasal 
mucosa 3 h, but not 24 and 48 h, after narrow-band UVB irradiation at a dose of 600 
mJ/cm2 (Fig. 6A). No CPD-positive cells appeared in the nasal mucosa 3, 24, and 48 h 
after narrow-band UVB irradiation at a dose of 600 mJ/cm2 (Fig. 6B). 
 
Discussion 
In the present study, we showed that intranasal pre-irradiation with 310 nm narrow-
band UVB dose-dependently suppressed H1R mRNA upregulation in the nasal mucosa 
and TDI-provoked sneezes of TDI-sensitized rats as an AR model. Our previous study 




because of an increase of levels of both H1R mRNA and protein in their nasal mucosa.14 
Because sneeze is mediated by nasal trigeminal reflex through H1R,17 and H1R 
immunohistochemically localized in the epithelium, vessels and nerves of human nasal 
mucosa,18 the present findings suggest that suppression of TDI-induced increase in 
amount of H1R in the nasal mucosal nerves by narrow-band UVB is responsible for the 
suppression of TDI-induced sneezes in TDI-sensitized rats after intranasal irradiation 
with narrow-band UVB. Moreover, in our previous in vitro study, narrow-band UVB 
suppressed upregulation of both H1R mRNA and protein in human epithelial HeLa cells 
that endogenously express H1R.16 Our previous clinical study also showed that levels of 
H1R mRNA of the nasal mucosa was correlated with the intensity of allergic symptom in 
patients with AR.8 Therefore, it is suggested that intranasal pre-irradiation with narrow-
band UVB suppressed upregulation of neural H1R in the nasal mucosa, resulting in the 
suppression of nasal symptom in a rat model of AR.    
We reported that the suppression of ERK phosphorylation induced by narrow-band 
UVB in the protein kinase C delta (PKCδ)/ERK/poly(ADP-ribose) polymerase 1 
(PARP-1) signaling pathway is responsible for narrow-band UVB-induced inhibition of 
PMA-induced upregulation of H1R mRNA in HeLa cells.15,16 Therefore, it was 




mucosa of TDI-sensitized rats after intranasal narrow-band UVB irradiation was also 
due to its inhibition of ERK phosphorylation.  
It has been reported that intranasal irradiation using Rhinolight (Rhinolight Ltd., 
Szeged, Hungary), which contains visible light (70%), UVA (25%) and UVB (5%) was 
effective for AR treatment.19,20 It has also been reported that Rhinolight induced 
apoptosis of T cells and eosinophils in the nasal mucosa, and decreased levels of IL-5 
and eosinophilic cationic protein in the nasal discharge.19 Accordingly, it was possible 
that narrow-band UVB-induced suppression of H1R mRNA upregulation was due to 
induction of apoptosis in immunocompetent cells in the nasal mucosa. However, the 
hypothesis was unlikely, because only a few TUNEL-positive nasal mucosal cells were 
induced after intranasal irradiation with 310 nm narrow-band UVB at a dose of 600 
mJ/cm2 that inhibited upregulation of H1R gene expression. Moreover, the suppressive 
effects of upregulation of H1R gene expression lasted 24 h, but disappeared 48 h after 
irradiation with narrow-band UVB. Thus, apoptosis could not account for the 
reversibility of narrow-band UVB-induced inhibition of the upregulation of H1R 
mRNA.  
In the present study, intranasal narrow-band UVB irradiation with 310 nm at 600 




sensitized rats. Usually, UVB light causes specific DNA damage to produce CPD and 
pyrimidine pyrimidone (6-4) photoproducts.21,22 DNA damage is considered to be the 
most potent cause of UVB-induced apoptosis.23 However, intranasal narrow-band UVB 
irradiation at a dose of 600 mJ/cm2 induced apoptosis in a few nasal mucosal cells without 
inducing DNA damage. Therefore, it is suggested that apoptosis after low-dose narrow-
band UVB (600 mJ/cm2) irradiation is caused by mechanisms other than DNA damage, 
such as UVB-generated reactive oxygen species in cells.24-26 It has been reported that 
DNA damage of human nasal mucosa induced by a single UV irradiation is efficiently 
removed within a few days,27 and that failure to properly repair DNA damage may cause 
gene mutations, finally leading to carcinogenesis.27-30 Because low-dose narrow-band 
UVB (600 mJ/cm2) did not induce DNA damage in nasal mucosal cells in rats, intranasal 
phototherapy with 310 nm narrow-band UVB at a dose of 600 mJ/cm2 is safely applicable 
for the treatment of AR.4,15,16  
In both Japanese and American practice guidelines for AD, narrow-band UVB 
phototherapy is the second line treatment for refractory AD that is intractable to first line 
treatments, such as a topical agent.1,3 A recent review article concluded that phototherapy 
with UVA1 (340-400 nm) and narrow-band UVB are valid therapeutic options for patients 




weeks,32 after the irradiation dose is calculated based on the Minimal Erythema Dose or 
the patient’s skin phototype.32,33 Whereas, phototherapy with narrow-band UVB is the 
first line treatment for psoriasis.2 Japanese practice guidelines for psoriasis recommend 
that psoriasis is treated with narrow-band UVB phototherapy once to three times a week.34 
In the present study, the suppression of nasal symptom after pre-irradiation with low-dose 
narrow-band UVB lasted 24 h, but disappeared after 48 h in a rat model of AR, suggesting 
that a protocol of intranasal phototherapy with narrow-band UVB 3 times a week for the 
treatment of AR might work the same way as phototherapy for AD and psoriasis. However, 
further research is necessary to determine the appropriate frequency and intervals of 
intranasal narrow-band UVB phototherapy in patients with AR. 
In conclusion, intranasal 310 nm narrow-band UVB irradiation dose-dependently 
inhibited nasal symptom and H1R mRNA upregulation in the nasal mucosa of AR model 
rats. These findings suggested that intranasal narrow-band UVB irradiation inhibited the 
upregulation of H1R gene expression in the nasal mucosa, resulting in the suppression of 
nasal symptom. The suppression after intranasal narrow-band UVB irradiation at a dose 
of 600 mJ/cm2 was reversible without induction of DNA damage. It was suggested that 
low-dose narrow-band UVB phototherapy could be effectively and safely used for the AR 





1. Katayama I, Aihara M, Ohya Y, Saeki H, Shimojo N, Shoji S, et al. Japanese guidelines 
for atopic dermatitis 2017. Allergol Int 2017; 66: 230-47. 
2. Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le maître M, et al. Efficacy of 
psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a 
systematic literature review. J Eur Acad Dermatol Venereol 2012; 26: 11-21.  
3. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, et al. 
Guidelines of care for the management of atopic dermatitis: section 3. Management and 
treatment with phototherapy and systemic agents. J Am Acad Dermatol 2014; 71: 327-49. 
4. Kitamura Y, Mizuguchi H, Okamoto K, Kitayama M, Fujii T, Fujioka A, et al. 
Irradiation with narrowband-ultraviolet B suppresses phorbol ester-induced up-regulation 
of H1 receptor mRNA in HeLa cells. Acta Otolaryngol 2016; 136: 409-13. 
5. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic 
Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World 
Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(suppl 86): 8-160. 
6. Iriyoshi N, Takeuchi K, Yuta A, Ukai K, Sakakura Y. Increased expression of histamine 
H1 receptor mRNA in allergic rhinitis. Clin Exp Allergy 1996; 26: 379-85. 




regulation of histamine receptor-1 in epithelial, mucus and inflammatory cells in 
perennial allergic rhinitis. Clin Exp Allergy 2005: 35: 1443-8. 
8. Mizuguchi H, Kitamura Y, Kondo Y, Kuroda W, Yoshida H, Miyamoto Y, et al. 
Preseasonal prophylactic treatment with antihistamines suppresses nasal symptoms and 
expression of histamine H1 receptor mRNA in the nasal mucosa of patients with 
pollinosis. Methods Find Exp Clin Pharmacol 2010; 32: 745-8. 
9. Nurul IM, Mizuguchi H, Shahriar M, Venkatesh P, Maeyama K, Mukherjee PK, et al. 
Albizia lebbeck suppresses histamine signaling by the inhibition of histamine H1 receptor 
and histidine decarboxylase gene transcriptions. Int Immunopharmacol 2011; 11: 1766-
72. 
10. Das AK, Mizuguchi H, Kodama M, Dev S, Umehara H, Kitamura Y, et al. Sho-seiryu-
to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal 
allergy model rats. Allergol Int 2009; 58: 81-8. 
11. Matsushita C, Mizuguchi H, Niino H, Sagesaka Y, Masuyama K, Fukui H. 
Identification of epigallocatechin-3-O-gallate as an active constituent in tea extract that 
suppresses transcriptional up-regulations of the histamine H1 receptor and interleukin-4 
genes. J Trad Med 2008; 25: 133-42. 




wild grape on the signaling of histamine H1 receptor gene expression responsible for the 
pathogenesis of allergic rhinitis. J Med Invest 2018; 65: 242-50. 
13. Aurpita S, Mizuguchi H, Kitamura Y, Fujino H, Yabumoto M, Takeda N, et al. Effect 
of royal jelly and Brazilian green propolis on the signaling for histamine H1 receptor and 
interleukin-9 gene expressions responsible for the pathogenesis of the allergic rhinitis. 
Biol Pharm Bull 2018; 41: 1440-7. 
14. Kitamura Y, Miyoshi A, Murata Y, Kalubi B, Fukui H, Takeda N, et al. Effect of 
glucocorticoid on upregulation of histamine H1 receptor mRNA in nasal mucosa of rats 
sensitized by exposure to toluene diisocyanate. Acta Otolaryngol 2004; 124: 1053-8. 
15. Mizuguchi H, Terao T, Kitai M, Ikeda M, Yoshimura Y, Das AK, et al. Involvement 
of protein kinase Cδ/extracellular signal-regulated kinase/poly (ADP-ribose) polymerase-
1 (PARP-1) signaling pathway in histamine-induced up-regulation of histamine H1 
receptor gene expression in HeLa cells. J Biol Chem 2011; 286: 30542-51. 
16. Fujii T, Kitamura Y, Mizuguchi H, Okamoto K, Sanada N, Yamada T, et al. Effect of 
irradiation with narrowband-ultraviolet B on up-regulation of histamine H1 receptor 
mRNA and induction of apoptosis in HeLa cells and nasal mucosa of rats. J Pharmacol 
Sci 2018; 138: 54-62. 





18. Nakaya M, Takeuchi N, Kondo K. Immunohistochemical localization of histamine 
receptor subtypes in human inferior turbinates. Ann Otol Rhinol Laryngol 2004; 113: 552-
7. 
19. Koreck AI, Csoma Z, Bodai L, Ignacz F, Kenderessy AS, Kadocsa E, et al. 
Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis. J 
Allergy Clin Immunol 2005; 115: 541-7. 
20. Bella Z, Kiricsi A, Viharosne ED, Dallos A, Perenyi A, Kiss M, et al. 
Rhinophototherapy in persistent allergic rhinitis. Eur Arch Otorhinolaryngol 2017; 274: 
1543-50. 
21. Ikehata H, Ono T. The mechanisms of UV mutagenesis. J Radiat Res 2011; 52: 115-
25. 
22. Cadet J, Douki T. Formation of UV-induced DNA damage contributing to skin cancer 
development. Photochem Photobiol Sci 2018; 17: 1816-41. 
23. Kulms D, Schwarz T. Independent contribution of three different pathways to 
ultraviolet-B-induced apoptosis. Biochem Pharmacol 2002; 64: 837-41. 
24. Chang H, Oehrl W, Elsner P, Thiele JJ. The role of H2O2 as a mediator of UVB-




25. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J 
Cereb Blood Flow Metab 2001; 21: 2-14. 
26. Dalton T, Shertzer H, Puga A. Regulation of gene expression by reactive oxygen. 
Annu Rev Pharmacol Toxicol 1999; 39: 67-101. 
27. Mitchell D, Paniker L, Sanchez G, Bella Z, Garaczi E, Szell M, et al. Molecular 
response of nasal mucosa to therapeutic exposure to broad-band ultraviolet radiation. J 
Cell Mol Med 2010; 14: 313-22. 
28. Aufiero BM, Talwar H, Young C, Krishnan M, Htfield JS, Lee HK, et al. Narrow-
band UVB induces apoptosis in human keratinocytes. J Photochem Photobiol,B 2006; 
82: 132-9. 
29. Matsumura Y, Ananthaswany HN. Toxic effects of ultraviolet radiation on the skin. 
Toxicol Appl Pharmacol 2004; 195: 298-308. 
30. Koreck A, Szechenyi A, Morocz M, Cimpean A, Bella Zs, Garaczi E, et al. Effects of 
intranasal phototherapy on nasal mucosa in patients with allergic rhinitis. J Photochem 
Photobiol, B 2007; 89: 163-9. 
31. Garritsen FM, Brouwer MW, Limpens J, Spuls PL. Photo(chemo)therapy in the 
management of atopic dermatitis: an updated systematic review with implications for 




32. Rodenbeck DL, Silverberg JI, Silververg NB. Phototherapy for atopic dermatitis. Clin 
Dermatol 2016; 34: 607-13. 
33. Pérez-Ferriols A. The minimal erythema dose (MED) project: in search of consensus 
on phototesting. Actas Dermosifiliogr 2013; 104: 541-2. 
34. Morita A, Eto T, Torii H, Ito T, Nemoto O, Kamide R, et al. [Guidelines for 

















Fig. 1 Experimental protocol. Rats were sensitized with 10 µl of a 10% solution of TDI 
in ethyl acetate, which was applied to the bilateral nasal vestibule on day 1-5 and day 8-
12. Narrow-band UVB of 310 nm was irradiated intranasally at doses of 200, 600 and 
1400 mJ/cm2 on day 22. Three hours after narrow-band UVB irradiation, we applied TDI 
to the bilateral nasal vestibule again to provoke nasal symptom. Immediately after TDI 
provocation, the number of sneezes was counted during 10 min. 
 
Fig. 2 Effects of intranasal irradiation with 310 nm narrow-band UVB on TDI-induced 
up-regulation of H1R mRNA of the nasal mucosa (A) and sneezes (B) of TDI-sensitized 
rats. Narrow-band UVB at doses of 200, 600 and 1400 mJ/cm2 was irradiated intranasally 
through bilateral nostrils of rats. Three hours after narrow-band UVB irradiation, TDI 
was applied again to provoke nasal symptom. Immediately after TDI provocation, the 
number of sneezes was counted during 10 min. The nasal mucosa of rats was dissected 4 
h after TDI provocation. We determined H1R mRNA level using real-time PCR. Control 
rats were treated with vehicle. The data are expressed as means ± SEM. n = 9 (200 
mJ/cm2), 8 (600 mJ/cm2), 7 (1400 mJ/cm2), 20 (TDI without irradiation), 20 (control). ##p 





Fig. 3 Effects of intranasal irradiation with 310 nm narrow-band UVB on induction of 
apoptosis in nasal mucosa cells of TDI-sensitized rats. Narrow-band UVB at doses of 200, 
600 and 1400 mJ/cm2 was irradiated intranasally through bilateral nostrils of rats. Three 
hours after narrow-band UVB irradiation, TDI was applied to the nasal vestibule to induce 
nasal symptom. Four hours after provocation, the nasal mucosa of rats was dissected, 
fixed in 4% paraformaldehyde, embedded in OCT compound, and rapidly frozen. The 
tissue was cut into 10 µm-thick sections. The tissue sections were stained using DeadEnd 
Fluorometric TUNEL System, counter-stained with propidium iodide and observed using 
a fluorescent microscope. Control rats were treated with vehicle. As a positive control, 
the nasal mucosa of control rats was treated with DNase. Apoptotic cells were indicated 
as green fluorescence and nuclei were indicated as red fluorescence. Scale bar indicates 
50 µm. 
 
Fig. 4 Effects of intranasal irradiation with 310 nm narrow-band UVB on UV-induced 
DNA damage in nasal mucosa cells of TDI-sensitized rats. Narrow-band UVB at doses 
of 200, 600 and 1400 mJ/cm2 was irradiated intranasally through bilateral nostrils of rats. 




to induce nasal symptom. Four hours after provocation, the nasal mucosa of rats was 
dissected, fixed in 4% paraformaldehyde, embedded in OCT compound, and rapidly 
frozen. The tissue was cut into 10 µm-thick sections. The tissue sections were 
immunostained using anti-CPD antibody, counter stained with propidium iodide, and 
observed using a fluorescent microscope. Control rats were treated with vehicle. CPD-
positive cells were indicated as green fluorescence, and nuclei were indicated as red 
fluorescence. Scale bar indicates 50 µm. 
 
 
Fig. 5 Time course of TDI-induced H1R mRNA up-regulation in the nasal mucosa (A) 
and sneezes (B) after intranasal irradiation with 310 nm narrow-band UVB of TDI 
sensitized rats. Narrow-band UVB at a dose of 600 mJ/cm2 was irradiated intranasally 
through bilateral nostrils of rats. TDI provocation was performed 3 h, 24 h, and 48 h later. 
Immediately after TDI provocation, we counted the number of sneezes during 10 min. 
Four hours after TDI provocation, the nasal mucosa was dissected. H1R gene expression 
level was determined using real-time PCR. Control rats were treated with vehicle. The 
data are presented as means ± SEM. n = 3 (3 h), 4 (24 h), 3 (48 h), 4 (TDI without 





Fig. 6 Time course of induction of apoptosis (A) and DNA damage (B) in the nasal 
mucosa after intranasal irradiation with 310 nm narrow-band UVB of TDI-sensitized rats. 
narrow-band UVB at a dose of 600 mJ/cm2 was irradiated intranasally through bilateral 
nostrils of rats. TDI provocation was performed 3 h, 24 h, and 48 h after narrow-band 
UVB irradiation. Four hours after provocation, the nasal mucosa of rats was dissected 
fixed in 4% paraformaldehyde, embedded in OCT compound, and rapidly frozen. The 
tissue was cut into 10 µm-thick sections. The tissue sections were stained using DeadEnd 
Fluorometric TUNEL System and anti-CPD antibody, counter-stained with propidium 
iodide, and observed using a fluorescent microscope. (A) Apoptotic cells and (B) CPD-
positive cells were indicated as green fluorescence, and nuclei were indicated as red 
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